Notices for publication in the OJ nº T-403/16 of Tribunal General de la Unión Europea, December 15, 2017

• Resolution Date: December 15, 2017
• Issuing Organization: Tribunal General de la Unión Europea
• Decision Number: T-403/16

Judgment of the General Court of 20 November 2017 - Stada Arzneimittel v EUIPO - Urgo recherche innovation et développement (Immunostad)

(Case T-403/16) ¹

(EU trade mark - Invalidity proceedings - Application for the EU word mark Immunostad - Earlier national word mark ImmunoStim - Relative ground for refusal - Similarity of the trade marks - Likelihood of confusion - Article 8(1)(b) and Article 53(1)(a) of Regulation (EC) No 207/2009 (now Article 8(1)(b) and Article 60(1)( a) of Regulation (EU) 2017/1001) - Non-negligible part of the relevant public - Obligation to state reasons - Article 75 of Regulation No 207/2009 (now Article 94 of Regulation 2017/1001))

Language of the case: English

Parties

Applicant: Stada Arzneimittel AG (Bad Vilbel, Germany) (represented by: R. Kaase and J.-C. Plate, lawyers)

Defendant: European Union Intellectual Property Office (represented by: initially, D. Botis and, subsequently, D. Walicka, acting as Agents)

Other party to the proceedings before EUIPO, intervener before the General Court: Urgo recherche innovation et développement, formerly Société de développement et de recherche industrielle, then Vivatech (Chenôve, France) (represented by: A. Sion and A. Delafond-Nielsen, lawyers)

Re:

Action brought against the...